3D tumor spheroid models for in vitro therapeutic screening: a systematic app...Arun kumar
The potential of a spheroid tumor model composed of cells in different proliferative and metabolic
states for the development of new anticancer strategies has been amply demonstrated. However, there
is little or no information in the literature on the problems of reproducibility of data originating from
experiments using 3D models. Our analyses, carried out using a novel open source software capable of
performing an automatic image analysis of 3D tumor colonies, showed that a number of morphology
parameters affect the response of large spheroids to treatment. In particular, we found that both
spheroid volume and shape may be a source of variability. We also compared some commercially
available viability assays specifically designed for 3D models. In conclusion, our data indicate the need
for a pre-selection of tumor spheroids of homogeneous volume and shape to reduce data variability to
a minimum before use in a cytotoxicity test. In addition, we identified and validated a cytotoxicity test
capable of providing meaningful data on the damage induced in large tumor spheroids of up to diameter
in 650 μm by different kinds of treatments.
Genes and Tissue Culture Technology Assignment (G6)Rohini Krishnan
The culture of cells in two dimensions does not reproduce the histological characteristics of a tissue for informative or useful study. Growing cells as three-dimensional (3D) models more analogous to their existence in vivo may be more clinically relevant.
3D tumor spheroid models for in vitro therapeutic screening: a systematic app...Arun kumar
The potential of a spheroid tumor model composed of cells in different proliferative and metabolic
states for the development of new anticancer strategies has been amply demonstrated. However, there
is little or no information in the literature on the problems of reproducibility of data originating from
experiments using 3D models. Our analyses, carried out using a novel open source software capable of
performing an automatic image analysis of 3D tumor colonies, showed that a number of morphology
parameters affect the response of large spheroids to treatment. In particular, we found that both
spheroid volume and shape may be a source of variability. We also compared some commercially
available viability assays specifically designed for 3D models. In conclusion, our data indicate the need
for a pre-selection of tumor spheroids of homogeneous volume and shape to reduce data variability to
a minimum before use in a cytotoxicity test. In addition, we identified and validated a cytotoxicity test
capable of providing meaningful data on the damage induced in large tumor spheroids of up to diameter
in 650 μm by different kinds of treatments.
Genes and Tissue Culture Technology Assignment (G6)Rohini Krishnan
The culture of cells in two dimensions does not reproduce the histological characteristics of a tissue for informative or useful study. Growing cells as three-dimensional (3D) models more analogous to their existence in vivo may be more clinically relevant.
Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.
3D Cell Culture is rapidly growing with incredible potential for industrial application and a widespread reach that can be seen across many different fields, such as 3D bioprinting and microfluidics.
The 2nd annual conference will explore these overlapping areas and will combine pioneering breakthroughs with scientific research to strengthen your commercial success. Join us for exclusive insight into key topics such as disease models, organoids, organ-on-a-chip technologies, Ipsc advances and CRISPR technology. Notable speakers on the agenda for 2018 will include experts from Aurelia Bioscience, ReInnervate Ltd, Cell and Gene Therapy Catapult, University College London, Novartis Institutes for Biomedical Research, Kugelmeiers, GSK, AstraZeneca, Roche and more!
Micro and nanoengineering approaches to developing gradient biomaterials sui...Dr. Sitansu Sekhar Nanda
Interface tissue found between soft and hard tissue regions such as cartilage-bone, tendon-bone, ligament-bone and other tissues. (e.g. dentin-enamel). Conventional Biomaterials are monophasic or composite materials are inefficient facilitating tissue formation. So, gradient materials are required for interface tissue engineering.
Development of cancer therapeutics is often carried out in 2D cultures prior to testing on animal model. In comparison to 2D cultures, discuss the potential of using 3D in vitro models for drug efficiency testing.
Building 3D Tissues for Transplantation and Drug ScreeningMelanie Matheu
Until now only the most elite laboratories have been able to build complex high-resolution tissue for drug screening and transplantation. Our technology has made building large 3D tissues as simple as pipetting your favorite cells.
SeedEZ 3D cell culture application notes - gel and drug embeddingLena Biosciences
SeedEZ 3D cell culture application notes - gel and drug embedding. Many inert polymers used as scaffolds for 3D cell cultures and colony formation are also used in drug delivery systems both in vitro and in vivo. Read this practical guide to learn how SeedEZ lets you merge these two worlds in order to integrate 3D cell cultures into standard drug delivery and testing applications.
By incorporating or adding drugs to SeedEZ, or in polymer matrices embedded in SeedEZ, dosage forms which release a drug over a period of time may be prepared in a desired shape and size. More importantly, all SeedEZ-based dosage forms may be tested in situ, with cells in a 3D cell culture. SeedEZ wicks most sol-state hydrogels, hydrogel precursors, semisolid media, excipient formulations, pharmaceuticals and test compounds. As a result, SeedEZ offers a novel 3D framework for (A) development of sustained release drug delivery systems that are simple to make and convenient to use in vitro; (B) localized or distributed drug delivery into 3D cell cultures using spot-a-culture and spot-a-drug approach, wick, dip or SeedEZ-stack method; (C) gradient formation and testing of drug combination strategies; (D) quality control testing and assurance; and (E) development of test platforms for quasi-steady drug release.
Notably, in most diffusion-driven drug delivery systems, a drug release rate declines in time. A degradable polymer matrix embedded in SeedEZ may enable quasi-steady drug release from a defined volume, defined by SeedEZ, when the matrix degradation rate is adjusted to compensate for this decline via increased drug permeability from the SeedEZ/polymer matrix system.
The application note covers use of common biomaterials, including extracellular matrix hydrogels (Collagen and Matrigel), gels from natural sources for spheroid cultures and controlled drug release (Agarose, Alginate, Methylcellulose, Gelatin), and synthetic materials such as Poloxamers (Pluronic - used for cell encapsulation, drug delivery and pharmaceutical formulations), and Carbomers used in ocular, transdermal, oral and nasal delivery systems.
SeedEZ 3D cell culture methods and protocols - tissue culture coatingLena Biosciences
SeedEZ 3D cell culture methods and protocols – tissue culture coating. 3D culturing conditions influence selection and application of coatings for anchorage-dependent cells. Depending on cell types and research objectives, SeedEZ may be coated or uncoated. If coated, SeedEZ may be coated with ligands which promote cell adhesion, or molecules which prevent cell adhesion to the SeedEZ substrate. The former provides a 3D network of cells adhered to and spread inside the SeedEZ. The latter provides an aggregate 3D cell culture model or 3D cell spheroids cultured suspended within the interior of the SeedEZ. Follow our user guidelines to learn which coatings are best suited for your application, whether spheroid cultures or 3D cell cultures of substrate adhered cells. Coating recommendations for diverse 3D cells culture models and detailed coating protocols for bone 3D cell culture models (cultured up to 8 weeks) are provided.
Cuckoo Search Optimization of Blebs in Human Embryonic Stem CellsIJMERJOURNAL
ABSTRACT: The main aim of this project is to segment the bleb from human embryonic stem cells (hESC). The behavior of bleb can be used to distinguish apoptotic bleb from the healthy bleb. The health of the human embryonic stem cells can be determined using the portion of bleb formed on the surface of the stem cells. The complete bleb formation contains bleb extraction and retraction. This paper uses the active contour algorithm for the segmentation of bleb from human embryonic stem cells. The output of the segmentation, input video and area of bleb can be used as an input to the optimization process. The cuckoo search algorithm is utilized for optimization, which inspired from the brooding parasitism will enhance the segmentation result. The proposed method attains the quick and accurate analysis in the bleb extraction process
3D polymer scaffolds offer great advantages for development of robust cell-based models. Here is a brief introduction to 3D Biotek's scaffold (3D Insert) and applications to recreate breast cancer and blood cancer in vitro models.
Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.
3D Cell Culture is rapidly growing with incredible potential for industrial application and a widespread reach that can be seen across many different fields, such as 3D bioprinting and microfluidics.
The 2nd annual conference will explore these overlapping areas and will combine pioneering breakthroughs with scientific research to strengthen your commercial success. Join us for exclusive insight into key topics such as disease models, organoids, organ-on-a-chip technologies, Ipsc advances and CRISPR technology. Notable speakers on the agenda for 2018 will include experts from Aurelia Bioscience, ReInnervate Ltd, Cell and Gene Therapy Catapult, University College London, Novartis Institutes for Biomedical Research, Kugelmeiers, GSK, AstraZeneca, Roche and more!
Micro and nanoengineering approaches to developing gradient biomaterials sui...Dr. Sitansu Sekhar Nanda
Interface tissue found between soft and hard tissue regions such as cartilage-bone, tendon-bone, ligament-bone and other tissues. (e.g. dentin-enamel). Conventional Biomaterials are monophasic or composite materials are inefficient facilitating tissue formation. So, gradient materials are required for interface tissue engineering.
Development of cancer therapeutics is often carried out in 2D cultures prior to testing on animal model. In comparison to 2D cultures, discuss the potential of using 3D in vitro models for drug efficiency testing.
Building 3D Tissues for Transplantation and Drug ScreeningMelanie Matheu
Until now only the most elite laboratories have been able to build complex high-resolution tissue for drug screening and transplantation. Our technology has made building large 3D tissues as simple as pipetting your favorite cells.
SeedEZ 3D cell culture application notes - gel and drug embeddingLena Biosciences
SeedEZ 3D cell culture application notes - gel and drug embedding. Many inert polymers used as scaffolds for 3D cell cultures and colony formation are also used in drug delivery systems both in vitro and in vivo. Read this practical guide to learn how SeedEZ lets you merge these two worlds in order to integrate 3D cell cultures into standard drug delivery and testing applications.
By incorporating or adding drugs to SeedEZ, or in polymer matrices embedded in SeedEZ, dosage forms which release a drug over a period of time may be prepared in a desired shape and size. More importantly, all SeedEZ-based dosage forms may be tested in situ, with cells in a 3D cell culture. SeedEZ wicks most sol-state hydrogels, hydrogel precursors, semisolid media, excipient formulations, pharmaceuticals and test compounds. As a result, SeedEZ offers a novel 3D framework for (A) development of sustained release drug delivery systems that are simple to make and convenient to use in vitro; (B) localized or distributed drug delivery into 3D cell cultures using spot-a-culture and spot-a-drug approach, wick, dip or SeedEZ-stack method; (C) gradient formation and testing of drug combination strategies; (D) quality control testing and assurance; and (E) development of test platforms for quasi-steady drug release.
Notably, in most diffusion-driven drug delivery systems, a drug release rate declines in time. A degradable polymer matrix embedded in SeedEZ may enable quasi-steady drug release from a defined volume, defined by SeedEZ, when the matrix degradation rate is adjusted to compensate for this decline via increased drug permeability from the SeedEZ/polymer matrix system.
The application note covers use of common biomaterials, including extracellular matrix hydrogels (Collagen and Matrigel), gels from natural sources for spheroid cultures and controlled drug release (Agarose, Alginate, Methylcellulose, Gelatin), and synthetic materials such as Poloxamers (Pluronic - used for cell encapsulation, drug delivery and pharmaceutical formulations), and Carbomers used in ocular, transdermal, oral and nasal delivery systems.
SeedEZ 3D cell culture methods and protocols - tissue culture coatingLena Biosciences
SeedEZ 3D cell culture methods and protocols – tissue culture coating. 3D culturing conditions influence selection and application of coatings for anchorage-dependent cells. Depending on cell types and research objectives, SeedEZ may be coated or uncoated. If coated, SeedEZ may be coated with ligands which promote cell adhesion, or molecules which prevent cell adhesion to the SeedEZ substrate. The former provides a 3D network of cells adhered to and spread inside the SeedEZ. The latter provides an aggregate 3D cell culture model or 3D cell spheroids cultured suspended within the interior of the SeedEZ. Follow our user guidelines to learn which coatings are best suited for your application, whether spheroid cultures or 3D cell cultures of substrate adhered cells. Coating recommendations for diverse 3D cells culture models and detailed coating protocols for bone 3D cell culture models (cultured up to 8 weeks) are provided.
Cuckoo Search Optimization of Blebs in Human Embryonic Stem CellsIJMERJOURNAL
ABSTRACT: The main aim of this project is to segment the bleb from human embryonic stem cells (hESC). The behavior of bleb can be used to distinguish apoptotic bleb from the healthy bleb. The health of the human embryonic stem cells can be determined using the portion of bleb formed on the surface of the stem cells. The complete bleb formation contains bleb extraction and retraction. This paper uses the active contour algorithm for the segmentation of bleb from human embryonic stem cells. The output of the segmentation, input video and area of bleb can be used as an input to the optimization process. The cuckoo search algorithm is utilized for optimization, which inspired from the brooding parasitism will enhance the segmentation result. The proposed method attains the quick and accurate analysis in the bleb extraction process
3D polymer scaffolds offer great advantages for development of robust cell-based models. Here is a brief introduction to 3D Biotek's scaffold (3D Insert) and applications to recreate breast cancer and blood cancer in vitro models.
3D Cell Culture technologies Patent Landscape Sample 2016 Knowmade
The patent landscape related to 3D cell technologies is very open, involving important academic applicants as well as small companies. It includes over 2,500 patent families and involves over 1,000 patent applicants.
The report provides essential patent data for 3D cell culture technologies including:
• Time evolution of patent publications and countries of patent filings
• Current legal status of patents
• Ranking of main patent applicants
• Joint developments and IP collaboration network of main patent applicants
• Key patents
• Granted patents near expiration.
• Relative strength of main companies IP portfolio
• 3D cell culture IP profiles of 10+ major companies with key patents, partnerships, and IP strength and strategy
Multiplexing cytotoxicity measurements in spheroids on normal and tumour tissueDelyanIvanov
The presentation highlights affordable, convenient, and amenable to validation methods to determine cytotoxic dose-response in spheroids
We have used readily-available standard lab equipment and open source platforms
A free Fiji( ImageJ) macro is disclosed aimed at automated image analysis of 3D spheroids
Leveraging Vision Zero and Black Lives Matter to Achieve Transportation Safet...Amanda Leahy
Pecha Kucha presented by Amanda Leahy at Pro Walk Pro Bike Pro Place 2016 in Vancouver, BC. Includes speaker notes.
Describes connection between Vision Zero and Black Lives Matter Movement (and Campaign Zero), discusses trajectory of transportation safety inequity and disproportionate impact of traffic fatalities/injuries on low income and communities of color, emphasizes importance of prioritizing social and environmental justice and a systematic approach to initiatives targeting traffic safety
Journal club: iPSC derived myelinoids to study myelin biology of humansLeena Shingavi
This is a journal club presentation on the manuscript by Owen et al, published in May 2021 in the journal Developmental cell. It describes how the myelinoids were derived from the iPSCs and can be considered as model to study myelin biology.
Newer concept, definition and theory of cancer by dr. rkdhaugoda of Nepaldr.rajkumar dhaugoda
New definition and new theory (stem cell-microRNA Theory) of cancer.General concept of cancer
by
CTGU, YICHANG CHINA-dr. rk dhaugoda
Visiting Assistant professor ( FROM NEPAL)
Accelerating the Delivery of New Treatments for Children with Neuroblastoma 2...Scintica Instrumentation
Neuroblastoma is a tumour arising from anomalies in the development of the sympathic nervous system and still accounts for 13% of all cancer-related death in children due to resistant, relapsing and metastatic diseases. There is an urgent need for the development of new treatment against high-risk relapsed neuroblastoma.
Overview:
Here we will discuss the ICR Paediatric Mouse Hospital approach which integrates more advanced mouse modelling, such as the use of genetically-engineered mouse (GEM) models and patient-derived xenografts to accelerate the discovery and evaluation of novel therapeutic strategies and help shape the clinical trial pipeline priorities for children with high-risk relapsing/refractory neuroblastoma.
We will also highlight the pivotal role of MRI within the Mouse Hospital which includes:
Enhancing and accelerating preclinical trials
Quantitatively inform on tumour phenotype and tumour response to treatment to:
Develop in vivo models that emulate the clinical treatment resistant phenotype using chemotherapy-dose escalation protocol
Characterize tumour spatial heterogeneity and evolution over treatment and guide the pathological and molecular characterization of the resistant phenotype
Finally we will also discuss how the compact, cryogen-free and user-friendly Aspect Imaging M-Series has transformed our way of working within the mouse hospital by providing a shared and easily accessible resource for tumour screening (with minimal onboarding) .
New definition and new theory (stem cell-microRNA Theory) of cancer-by dr.ra...Rajkumar Dhaugoda
Lecture notes on New definition and new theory (stem cell-microRNA Theory) of cancer
General concept of cancer
By Dr.Rkdhaugoda
CTGU, YICHANG CHINA-
Visiting Assistant professor ( FROM NEPAL)
2014- MAY-5th
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Nutraceutical market, scope and growth: Herbal drug technology
The Development of a 3D Cell Culture System for Retinoblastoma
1. Private & Confidential
The Development of a Three-
Dimensional Cell Culture System for
Retinoblastoma Cells
Ayling Dominguez
Glorymar Ibáñez
Dr. Hakim Djaballah
Dr. JoAnn Gensert
2. Private & Confidential
Retinoblastoma
• Rare eye cancer caused by
mutations in both RB1 genes
• Tumor grows in sleeves/cuffs
– Sporadic cancer
– Hereditary cancer
Tumor
Tumor
6. Private & Confidential
Workflow
• Retinoblastoma (Y79) cells incubated with NS and
without NS in a 6-well plate
Nanoshuttles
• Plate placed on magnetic dot drive to aggregate
Magnets
• Cells cultured in incubator
• Images taken to determine dimensional morphology
Culturing and Imaging
7. Private & Confidential
3D Cell Culture System Assessment
Cell aggregation increases over course of study in
a ring-like formation.
Day 7Day 2 Day 3 Day 4 Day 5 Day 6Day 1
withNSwithoutNS
1000µm
8. Private & Confidential
Cell Viability Assessment
2D culture: lack of uniform clumps due to lack of magnetization
3D culture: novel growth in uniform clumps, viability surrounding ring
withNSwithoutNS
Calcein AM (green channel)Brightfield
500µm
9. Private & Confidential
Compound Screening
• The compounds screened were:
– 100 nM of TOPOTECAN
– 10 μM of MELPHALAN
– 100 μM of CISPLATIN
Add alamarBlue Reagent (10%
volume of culture) directly to
medium
Image plates with LEADseeker™
homogeneous imaging system
Treat cells
with compounds
Incubate
37°C
11. Private & Confidential
Subsequent Research
• Screening selected compounds (topotecan,
melphalan, and cisplatin) in three-dimensional
culture system
12. Private & Confidential
Acknowledgements
• Glorymar Ibáñez
• Dr. Hakim Djaballah
• Memorial Sloan Kettering Cancer Center
High-Throughput Core Screening Facility
• Dr. JoAnn Gensert
